These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

299 related items for PubMed ID: 29756998

  • 1. LDHA upregulation independently predicts poor survival in lung adenocarcinoma, but not in lung squamous cell carcinoma.
    Yu C, Hou L, Cui H, Zhang L, Tan X, Leng X, Li Y.
    Future Oncol; 2018 Oct; 14(24):2483-2492. PubMed ID: 29756998
    [Abstract] [Full Text] [Related]

  • 2. Elevated PHD2 expression might serve as a valuable biomarker of poor prognosis in lung adenocarcinoma, but no lung squamous cell carcinoma.
    Xu XL, Gong Y, Zhao DP.
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8731-8739. PubMed ID: 30575913
    [Abstract] [Full Text] [Related]

  • 3. Increased GOLM1 Expression Independently Predicts Unfavorable Overall Survival and Recurrence-Free Survival in Lung Adenocarcinoma.
    Liu X, Chen L, Zhang T.
    Cancer Control; 2018 Dec; 25(1):1073274818778001. PubMed ID: 29843532
    [Abstract] [Full Text] [Related]

  • 4. Elevated expression of Twinfilin-1 is correlated with inferior prognosis of lung adenocarcinoma.
    Kaishang Z, Xue P, Shaozhong Z, Yingying F, Yan Z, Chanjun S, Zhenzhen L, Xiangnan L.
    Life Sci; 2018 Dec 15; 215():159-169. PubMed ID: 30391462
    [Abstract] [Full Text] [Related]

  • 5. UBE2D1 RNA Expression Was an Independent Unfavorable Prognostic Indicator in Lung Adenocarcinoma, but Not in Lung Squamous Cell Carcinoma.
    Hou L, Li Y, Wang Y, Xu D, Cui H, Xu X, Cong Y, Yu C.
    Dis Markers; 2018 Dec 15; 2018():4108919. PubMed ID: 30420903
    [Abstract] [Full Text] [Related]

  • 6. Aberrant S100A16 expression might be an independent prognostic indicator of unfavorable survival in non-small cell lung adenocarcinoma.
    Chen D, Luo L, Liang C.
    PLoS One; 2018 Dec 15; 13(5):e0197402. PubMed ID: 29746588
    [Abstract] [Full Text] [Related]

  • 7. SPC25 upregulation increases cancer stem cell properties in non-small cell lung adenocarcinoma cells and independently predicts poor survival.
    Chen J, Chen H, Yang H, Dai H.
    Biomed Pharmacother; 2018 Apr 15; 100():233-239. PubMed ID: 29432994
    [Abstract] [Full Text] [Related]

  • 8. The genomic alterations of lung adenocarcinoma and lung squamous cell carcinoma can explain the differences of their overall survival rates.
    Meng F, Zhang L, Ren Y, Ma Q.
    J Cell Physiol; 2019 Jul 15; 234(7):10918-10925. PubMed ID: 30549039
    [Abstract] [Full Text] [Related]

  • 9. PLEK2 Gene Upregulation Might Independently Predict Shorter Progression-Free Survival in Lung Adenocarcinoma.
    Zhang W, Li T, Hu B, Li H.
    Technol Cancer Res Treat; 2020 Jul 15; 19():1533033820957030. PubMed ID: 33084541
    [Abstract] [Full Text] [Related]

  • 10. High KRT8 Expression Independently Predicts Poor Prognosis for Lung Adenocarcinoma Patients.
    Xie L, Dang Y, Guo J, Sun X, Xie T, Zhang L, Yan Z, Amin H, Guo X.
    Genes (Basel); 2019 Jan 10; 10(1):. PubMed ID: 30634629
    [Abstract] [Full Text] [Related]

  • 11. High levels of CCL2 or CCL4 in the tumor microenvironment predict unfavorable survival in lung adenocarcinoma.
    Li L, Liu YD, Zhan YT, Zhu YH, Li Y, Xie D, Guan XY.
    Thorac Cancer; 2018 Jul 10; 9(7):775-784. PubMed ID: 29722145
    [Abstract] [Full Text] [Related]

  • 12. High ECT2 expression is an independent prognostic factor for poor overall survival and recurrence-free survival in non-small cell lung adenocarcinoma.
    Zhou S, Wang P, Su X, Chen J, Chen H, Yang H, Fang A, Xie L, Yao Y, Yang J.
    PLoS One; 2017 Jul 10; 12(10):e0187356. PubMed ID: 29088286
    [Abstract] [Full Text] [Related]

  • 13. Expression of SUMO1P3 Compared with SUMO1 is an Independent Predictor of Patient Outcome in Lung Adenocarcinoma.
    Su X, Wan Y, Xie L, Lin X, Zhao H, Ju X, Fang A.
    Med Sci Monit; 2019 Sep 06; 25():6691-6701. PubMed ID: 31489957
    [Abstract] [Full Text] [Related]

  • 14. System analysis of FHIT in LUAD and LUSC: The expression, prognosis, gene regulation network, and regulation targets.
    Situ Y, Gao R, Lei L, Deng L, Xu Q, Shao Z.
    Int J Biol Markers; 2022 Jun 06; 37(2):158-169. PubMed ID: 35254116
    [Abstract] [Full Text] [Related]

  • 15. Prognostic alternative mRNA splicing signature in non-small cell lung cancer.
    Li Y, Sun N, Lu Z, Sun S, Huang J, Chen Z, He J.
    Cancer Lett; 2017 May 01; 393():40-51. PubMed ID: 28223168
    [Abstract] [Full Text] [Related]

  • 16. LncRNAs are altered in lung squamous cell carcinoma and lung adenocarcinoma.
    Liu B, Chen Y, Yang J.
    Oncotarget; 2017 Apr 11; 8(15):24275-24291. PubMed ID: 27903974
    [Abstract] [Full Text] [Related]

  • 17. Differential MUC22 expression by epigenetic alterations in human lung squamous cell carcinoma and adenocarcinoma.
    Lin S, Tian C, Li J, Liu B, Ma T, Chen K, Gong W, Wang JM, Huang J.
    Oncol Rep; 2021 May 11; 45(5):. PubMed ID: 33786615
    [Abstract] [Full Text] [Related]

  • 18. Plakophilin-2 accelerates cell proliferation and migration through activating EGFR signaling in lung adenocarcinoma.
    Hao XL, Tian Z, Han F, Chen JP, Gao LY, Liu JY.
    Pathol Res Pract; 2019 Jul 11; 215(7):152438. PubMed ID: 31126818
    [Abstract] [Full Text] [Related]

  • 19. Integrative bioinformatics analysis the clinical value of KMT5A in different subtypes of lung cancer.
    Liu S, Tian W, Li B.
    Comput Biol Chem; 2022 Feb 11; 96():107603. PubMed ID: 34894606
    [Abstract] [Full Text] [Related]

  • 20. Downregulation of HOXA3 in lung adenocarcinoma and its relevant molecular mechanism analysed by RT-qPCR, TCGA and in silico analysis.
    Gan BL, He RQ, Zhang Y, Wei DM, Hu XH, Chen G.
    Int J Oncol; 2018 Oct 11; 53(4):1557-1579. PubMed ID: 30066858
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.